Mohamed Elbadawi

404 total citations
21 papers, 296 citations indexed

About

Mohamed Elbadawi is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Mohamed Elbadawi has authored 21 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in Mohamed Elbadawi's work include Histone Deacetylase Inhibitors Research (4 papers), Gastrointestinal motility and disorders (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Mohamed Elbadawi is often cited by papers focused on Histone Deacetylase Inhibitors Research (4 papers), Gastrointestinal motility and disorders (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Mohamed Elbadawi collaborates with scholars based in Germany, Sudan and Egypt. Mohamed Elbadawi's co-authors include Thomas Efferth, Ge Yan, Mona Dawood, Sabine M. Klauck, Mohamed‐Elamir F. Hegazy, Yoshikazu Sugimoto, Mohamed E.M. Saeed, Gerhard Bringmann, Nuha Mahmoud and Ramy M. Ammar and has published in prestigious journals such as International Journal of Molecular Sciences, Biochemical Pharmacology and Pharmacological Research.

In The Last Decade

Mohamed Elbadawi

20 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed Elbadawi Germany 9 165 47 31 29 27 21 296
Ellen Cristina Souza de Oliveira Brazil 7 186 1.1× 67 1.4× 21 0.7× 41 1.4× 28 1.0× 11 369
Swarnendu Bag India 12 123 0.7× 53 1.1× 25 0.8× 16 0.6× 37 1.4× 31 445
Malek Zihlif Jordan 12 165 1.0× 49 1.0× 43 1.4× 19 0.7× 18 0.7× 36 371
Min Yin China 15 167 1.0× 26 0.6× 24 0.8× 23 0.8× 63 2.3× 29 418
Mohd Imran Khan India 13 153 0.9× 34 0.7× 28 0.9× 77 2.7× 22 0.8× 40 401
Chenglin Mu China 9 130 0.8× 38 0.8× 18 0.6× 51 1.8× 29 1.1× 15 317
Aswathy R. Devan India 10 99 0.6× 83 1.8× 28 0.9× 22 0.8× 59 2.2× 18 303
Juanjuan Wang China 11 128 0.8× 31 0.7× 31 1.0× 28 1.0× 72 2.7× 27 322
Xiaoqin Zheng China 13 156 0.9× 41 0.9× 47 1.5× 35 1.2× 74 2.7× 27 397

Countries citing papers authored by Mohamed Elbadawi

Since Specialization
Citations

This map shows the geographic impact of Mohamed Elbadawi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Elbadawi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Elbadawi more than expected).

Fields of papers citing papers by Mohamed Elbadawi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Elbadawi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Elbadawi. The network helps show where Mohamed Elbadawi may publish in the future.

Co-authorship network of co-authors of Mohamed Elbadawi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Elbadawi. A scholar is included among the top collaborators of Mohamed Elbadawi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Elbadawi. Mohamed Elbadawi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Elbadawi, Mohamed & Thomas Efferth. (2024). In Vivo and Clinical Studies of Natural Products Targeting the Hallmarks of Cancer. Handbook of experimental pharmacology. 287. 95–121.
3.
Elbadawi, Mohamed, et al.. (2024). Aniquinazoline B, a Fungal Natural Product, Activates the μ‐Opioid Receptor. ChemMedChem. 19(19). e202400213–e202400213. 2 indexed citations
4.
Abdelghani, Mohammad, et al.. (2024). Tricuspid valve and right-heart chamber remodelling in elderly subjects with secondary tricuspid regurgitation. Acta cardiologica. Supplementum. 79(9). 1011–1020. 2 indexed citations
5.
Elbadawi, Mohamed, Joelle C. Boulos, Mona Dawood, et al.. (2023). The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells. Pharmaceutics. 15(4). 1107–1107. 5 indexed citations
6.
7.
Mahmoud, Nuha, Mohamed‐Elamir F. Hegazy, Walaa Wadie, et al.. (2022). Naphthoquinone derivatives as P-glycoprotein inducers in inflammatory bowel disease: 2D monolayers, 3D spheroids, and in vivo models. Pharmacological Research. 179. 106233–106233. 14 indexed citations
8.
Lu, Xiaohua, Mohamed Elbadawi, Sebastian Blatt, et al.. (2022). Artemisinin derivative FO-ARS-123 as a novel VEGFR2 inhibitor suppresses angiogenesis, cell migration, and invasion. Chemico-Biological Interactions. 365. 110062–110062. 8 indexed citations
9.
Ogbole, Omonike O., E. O. Ajaiyeoba, Taye B. Demissie, et al.. (2022). Flavanols from Tetrapleura tetraptera with cytotoxic activities. Fitoterapia. 160. 105206–105206. 5 indexed citations
10.
Elbadawi, Mohamed, et al.. (2022). Assessing the Influence of Dark Triad Personality Traits on Counterproductive Work Behaviour with Mediating Role of Selected Variables. International Business Research. 15(6). 103–103. 3 indexed citations
11.
Elbadawi, Mohamed, Ramy M. Ammar, Sabine M. Klauck, et al.. (2021). Anti-inflammatory and tight junction protective activity of the herbal preparation STW 5-II on mouse intestinal organoids. Phytomedicine. 88. 153589–153589. 27 indexed citations
12.
Kadioglu, Onat, Mohamed Elbadawi, Edmond Fleischer, & Thomas Efferth. (2021). Identification of Novel Anthracycline Resistance Genes and Their Inhibitors. Pharmaceuticals. 14(10). 1051–1051. 3 indexed citations
13.
14.
Elbadawi, Mohamed & Thomas Efferth. (2020). Organoids of human airways to study infectivity and cytopathy of SARS-CoV-2. The Lancet Respiratory Medicine. 8(7). e55–e56. 25 indexed citations
15.
Hegazy, Mohamed‐Elamir F., Mona Dawood, Nuha Mahmoud, et al.. (2020). 2α-Hydroxyalantolactone from Pulicaria undulata: activity against multidrug-resistant tumor cells and modes of action. Phytomedicine. 81. 153409–153409. 24 indexed citations
16.
Dawood, Mona, Mohamed‐Elamir F. Hegazy, Mohamed Elbadawi, et al.. (2020). Vitamin K3 chloro derivative (VKT-2) inhibits HDAC6, activates autophagy and apoptosis, and inhibits aggresome formation in hepatocellular carcinoma cells. Biochemical Pharmacology. 180. 114176–114176. 13 indexed citations
17.
Yan, Ge, Mohamed Elbadawi, & Thomas Efferth. (2020). Multiple cell death modalities and their key features (Review). World Academy of Sciences Journal. 111 indexed citations
18.
Saeed, Mohamed E.M., Victor Kuete, Mona Dawood, et al.. (2019). Collateral sensitivity of drug-resistant ABCB5- and mutation-activated EGFR overexpressing cells towards resveratrol due to modulation of SIRT1 expression. Phytomedicine. 59. 152890–152890. 18 indexed citations
19.
Mohamed, Magdi Awadalla, Amina Ibrahim Dirar, Mohamed Elbadawi, et al.. (2017). In silico assessment of the druggability of two novel germacranolides isolated from Capparis decidua (Forsk.) as carbonic anhydrase II inhibitors. Journal of Applied Pharmaceutical Science. 93–97. 1 indexed citations
20.
Elbadawi, Mohamed, et al.. (2015). Valproic Acid as a Potential Inhibitor of Plasmodium falciparum Histone Deacetylase 1 (PfHDAC1): An in Silico Approach. International Journal of Molecular Sciences. 16(2). 3915–3931. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ellen Cristina Souza de Oliveira Breakdown of academic impact, for papers by Swarnendu Bag Breakdown of academic impact, for papers by Malek Zihlif Breakdown of academic impact, for papers by Min Yin Breakdown of academic impact, for papers by Mohd Imran Khan Breakdown of academic impact, for papers by Chenglin Mu Breakdown of academic impact, for papers by Aswathy R. Devan Breakdown of academic impact, for papers by Juanjuan Wang Breakdown of academic impact, for papers by Xiaoqin Zheng
Rankless by CCL
2026